A new study has added valuable outcome data from adolescents 5 years after undergoing Roux-en-Y gastric bypass. By comparing outcomes from adolescents and adults, the study adds to the existing evidence base, highlighting metabolic and bariatric surgery as an increasingly valuable tool in the multidisciplinary management of adolescents with severe obesity.
Subscribe to Journal
Get full journal access for 1 year
only $17.42 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Pratt, J. S. A. et al. ASMBS pediatric metabolic and bariatric surgery guidelines, 2018. Surg. Obes. Relat. Dis. 14, 882–901 (2018).
Inge, T. H. et al. Five-year outcomes of gastric bypass in adolescents as compared with adults. N. Engl. J. Med. 380, 2136–2145 (2019).
Olbers, T. et al. Laparoscopic roux-en-y gastric bypass in adolescents with severe obesity (AMOS): a prospective, 5-year, Swedish nationwide study. Lancet Diabetes Endocrinol. 5, (174–183 (2017).
Inge, T. H. et al. Long-term outcomes of bariatric surgery in adolescents with severe obesity (FABS-5+): a prospective follow-up analysis. Lancet Diabetes Endocrinol. 5, 165–173 (2017).
Group, T. S. et al. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N. Engl. J. Med. 366, 2247–2256 (2012).
Kahn, S. E. et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N. Engl. J. Med. 355, 2427–2443 (2006).
Beamish, A. J., D’Alessio, D. A. & Inge, T. H. Controversial issues: when the drugs don’t work, can surgery provide a different outcome for diabetic adolescents? Surg. Obes. Relat. Dis. 11, 946–948 (2015).
Sjostrom, L. et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA 311, 2297–2304 (2014).
Mingrone, G. et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet 386, 964–973 (2015).
Beamish, A. J. et al. Cardiovascular effects of bariatric surgery. Nat. Rev. Cardiol. 13, 730–743 (2016).
T.O. serves as consultant for Ethicon Endo surgery as participant in global advisory board and in lecturing, is a member of an advisory board for NovoNordisk and has also lectured for AstraZeneca, Merck, Mölnlycke and SanofiAventis; all revenue to institution. A.J.B. declares no competing interests.
About this article
Cite this article
Beamish, A.J., Olbers, T. Metabolic and bariatric surgery in adolescents. Nat Rev Gastroenterol Hepatol 16, 585–587 (2019). https://doi.org/10.1038/s41575-019-0187-x